The Feasibility and Acceptability of a Gait Training Program Based on Telerehabilitation After St… (NCT07623018) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Feasibility and Acceptability of a Gait Training Program Based on Telerehabilitation After Stroke
Saudi Arabia12 participantsStarted 2027-08-01
Plain-language summary
Gait impairments following stroke significantly reduce functional mobility, making walking recovery a primary rehabilitation goal to improve safety, speed, and quality of life while reducing fall risk. Delivering interventions at home via technology can enhance adherence to home exercise programmes and increase therapy frequency and intensity. This study aims to determine the feasibility and acceptability of the Stroke Telerehabilitation for Enhanced Performance in Gait via Technology (STEP-Tech) intervention for patients with stroke in Saudi Arabia. The intervention will be delivered by trained physiotherapists in two phases. Phase one will take place in an outpatient setting, during which patients may require approximately three sessions over one week. Phase two will be home-based for four weeks.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
For stage one of the study:
* People with stroke aged \> 18 years living in Saudi Arabia.
* Diagnosed with ischemic or haemorrhagic stroke.
* People with stroke in the late-subacute or chronic phase ( ≥ 3 months after stroke onset).
* Patients can walk indoors for at least 10 meters with supervision and/or an assistive device (cane or walker).
* Patient with low fall risk (less than 20 seconds) based on the Timed Up and Go test (TUG).
* Ability to understand instructions and follow simple commands to participate in the study and give consent. Patients are required to obtain a score of seven or eight on the eight decisional capacity questionnaires that are relevant to the consent form content. These requirements are necessary to make sure that people can give consent. The decisional capacity questionnaire's content is based on the previously utilised University of California Brief Assessment Capacity to Consent (UBACC) questions that have been adjusted for the study's context.
* They are not currently participating in any other stroke rehabilitation study.
* Only those who can speak Arabic or English.
For stage 2 of the study (qualitative evaluation):
* Physiotherapists with experience working with people who have had a stroke (at least 2 years of experience).
* Carers aged 18 years or older who support patients during the intervention period
* Able to communicate in Arabic or English
Exclusion Criteria:
For stage one of the study :
* Patient with se…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of eligible participants out of screened participants
Timeframe: During the screening process
2
Proportion of ineligible participants out of screened participants
Timeframe: During the screening process
3
Number of participants enrolled
Timeframe: During the enrolment process
4
Retention rate
Timeframe: Recorded at week 6
5
Safety of intervention (any adverse events recorded)